网上平台被黑不给取款

EN|Investor Relations
The Board

Investor Relations

  • Corporate Governance
  • Announcements
  • Financial Reports
  • Company Presentations
  • Stock Price
  • Analyst Coverage
  • Investor Relations Contacts

The Board

Wang Chuncheng - Chairman and Non-executive Director


Mr. Wang Chuncheng, serves as an executive vice president of China Resources (Holdings) Company Limited (“CR Holdings”), concurrently serves as the chairman of the Board of China Resources Pharmaceutical Group Limited and also serves as the chairman of China Resources Sanjiu Medical & Pharmaceutical Company Limited (華潤(run)三九醫藥股份有限公司(“CR Sanjiu”), a company listed on Shenzhen Stock Exchange (stock code: 000999) and the chairman of China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (華(hua)潤江中製藥集團(tuan)有限責(ze)任公司). Mr. Wang has over 20 years of experience in corporate management, Mr. Wang holds a bachelor’s degree in economics from Jilin Institute of Finance and Trade (currently known as Jilin University of Finance and Economics). He joined CR Holdings in 1997.

Han Yuewei - Executive Director and Chief Executive Officer


Mr. Han Yuewei, was appointed as an executive Director, chief executive officer of the Company in October 2019. He also serves as the chairman of Dong-E-E-Jiao Company Limited(東阿(a)(a)阿(a)(a)膠(jiao)股份有(you)限公(gong)司(si))(Dong-E-E-Jiao) (the shares of which are listed on the Shenzhen Stock Exchange, Stock Code: 000423), and a director of CR Sanjiu and a director of China Resources Double-Crane Pharmaceutical Company Limited(華潤(run)雙鶴藥業股份有(you)限(xian)公司(si))(CR Double-Crane) (the shares of which are listed on the Shanghai Stock Exchange, Stock Code: 600062). Mr. Han served as an executive director of China Resources Medical Holdings Company Limited (“CR Medical”) (listed on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), stock code: 1515) from October 2017 to October 2019, during which he served as the chief executive officer of CR Medical and the general manager of China Resources Healthcare Group Limited, the controlling shareholder of CR Medical. Mr. Han worked for China Resources Land Limited (“CR Land”) (listed on the Stock Exchange, stock code: 1109) from October 2010 to October 2017, during which he served as deputy general manager of Shenyang Region, deputy general manager of Shenzhen Region, director of engineering and vice president of CR Land. Prior to joining CR Land, Mr. Han worked as the deputy director and director of the Bureau of Public Works of Shenzhen Municipality(深圳市建築工務署)from April 2002 to October 2010. Mr. Han obtained a master’s degree in construction economics and management from Tsinghua University(清(qing)華大(da)學)and a bachelor’s degree in construction management from Tsinghua University in July 1993 and July 1991 respectively.

Weng Jingwen - Executive Director, Chief Financial Officer and Vice President


Mdm. Weng Jingwen, was appointed as an executive Director, chief financial officer and vice president of the Company in July 2019, has 12 years of experience in financial management and auditing and 8 years of experience in strategic development and business analysis. Mdm. Weng also serves as a director of China Resources Pharmaceutical Holdings Company Limited (華潤醫藥控股有限公司), China Resources Pharmaceutical Investment Company Limited (華潤(run)醫藥(yao)投資有限公司), Beijing Pharmaceutical Co., Ltd. (北(bei)京醫藥集團有限(xian)責任公(gong)司), CR Pharmaceutical Commercial, CR Double-Crane, CR Sanjiu, Dong-E-E-Jiao, China Resources Biopharmaceutical (Shenzhen) Co., Ltd. (華潤生物醫藥(深圳)有限公司(si)), CR Care Company Limited. Mdm. Weng served as a general manager of internal audit department and strategic controller of China Resources Gas Group Limited (the shares of which are listed on the Stock Exchange), Stock Code: 1193), deputy strategic development controller of China Resources (Holdings) Company Limited (with a focus in pharmaceutical and healthcare areas). Mdm. Weng was previously engaged in financial management and auditing job in the International Business Machines Corporation and PricewaterhouseCoopers before joining China Resources Group. Mdm. Weng obtained a bachelor’s degree in economics from Zhejiang University and an MBA degree from the Hong Kong University of Science and Technology.

Tao Ran - Executive Director and Vice President


Mr. Tao Ran, was appointed as vice president of the Company in June 2021. He is concurrently a director of China Resources Jiangzhong Pharmaceutical Group Co., Ltd., a director of China Resources Zizhu Pharmaceutical Co., Ltd, a supervisor of China Resources Pharmaceutical Investment Company Limited, a supervisor of Beijing Pharmaceutical Co., Ltd., a supervisor of China Resources Pharmaceutical Commercial Group Company Limited, a supervisor of CR Sanjiu, a supervisor of CR Double-Crane, a supervisor of Dong-E-E-Jiao and has been a non-executive director of Immunotech Biopharm Ltd (a company listed on the Stock Exchange, stock code: 6978) since August 2021. Mr. Tao has been a deputy chief of Import Division I of China Resources National Corporation (currently known as China Resources Company Limited), a senior manager of Investment Division and a deputy general manager of China Resources Textiles (Holdings) Co., Ltd. and a senior director of Strategic Development Division and the general manager of Strategic Development Division of CR Pharmaceutical. Mr. Tao holds a bachelor’s degree in Engineering awarded by Shanghai Jiao Tong University, China and a master’s degree in Economics awarded by Beihang University, China.

Lin Guolong - Non-executive Director


Mr. Lin Guolong, has been a designated external director of the business unit of CR Holdings since August 2021. Mr. Lin had been deputy general manager of the finance department of CR Holdings from August 2004 to August 2011 and from July 2018 to August 2021. From August 2011 to July 2018, he was vice president and chief financial officer of CR Sanjiu. Mr. Lin holds a bachelor’s degree in Economics from the Accounting Department of Xiamen University and a Master of Business Administration degree from the University of South Australia.

Tan Ying - Non-executive Director


Mr. Tan Ying, has been vice president of CR Sanjiu since April 2013. Mr. Tan had been a director of the technology centre, chief technology officer and chief R&D technology officer at CR Sanjiu from January 2006 to July 2012. From July 2012 to March 2013, he was general manager of the CR Sanjiu R&D Centre. Mr. Tan held a bachelor’s degree in Chinese medicine from Anhui Academy of Chinese Medicine and a master’s degree and doctoral degree in integrated Chinese medicine from Guangzhou University of Chinese Medicine.

Hou Bo - Non-executive Director


Mr. Hou Bo, was appointed as a non-executive Director on March 2021 and joined the Beijing State-Owned Capital Operation And Management Center (“BSCOMC”) in 2019 and is currently an external task director of the BSCOMC. Mr. Hou has years of experience in financial management. He served as the director of the insurance and non-banking services department of the Beijing Municipal Bureau of Financial Work(北京市金融工作(zuo)局), the director of the financial market department of the Beijing Municipal Bureau of Financial Work(北京市金融(rong)工作(zuo)局), the deputy general manager (deputy bureau level) of the former Beijing Equity Exchange Center Co., Ltd.(北京股權交易(yi)中心(xin)有(you)限公司), and member of the Party Branch and deputy general manager of Zhongguancun Equity Exchange Service Group Co., Ltd.(中(zhong)關村股權交易服務集團有限公司). Mr. Hou graduated from the department of mechanical engineering of Tsinghua University in 1986 with a bachelor of engineering degree in forging and pressing. He graduated from the department of business and economics of Capital University of Economics and Business with a master degree in foreign trade operations and management in 1997 and obtained a doctor of engineering degree in resources industry economics from the school of earth sciences and resources of the China University of Geosciences, Beijing in 2009. He is also a senior international business engineer.

Qing Mei Ping Cuo - Non-executive Director


Mr. Qing Mei Ping Cuo was appointed as a non-executive Director in March 2021 and joined the BSCOMC in 2018 and is currently the deputy general manager of the second investment management department of the BSCOMC and a non-independent director of Hainan Jingliang Holdings Co., Ltd. (listed on the Shenzhen Stock Exchange, stock code: 000505). Mr. Qing Mei Ping Cuo has years of experience in the banking industry. He served as the vice branch manager of Tibet Bank in the Lhasa Economic and Technological Development Zone, the secretary of the Youth League Committee of Tibet Bank, the deputy general manager of the corporate business department and the secretary of the Youth League Committee of Tibet Bank, the branch manager of Tibet Bank in the Lhasa Economic and Technological Development Zone, the deputy secretary of the working committee of the Tibet Financial League(西(xi)藏(zang)金融團(tuan))(concurrently) and the deputy general manager of the comprehensive management department of the BSCOMC. Mr. Qing Mei Ping Cuo graduated from the department of foreign languages of Tsinghua University with a major in English in 2010 and graduated from the school of economics and management of Tsinghua University with a master degree of business administration in 2014.

Shing Mo Han Yvonne - Independent Non-executive Director


Mdm. Shing Mo Han Yvonne, BBS, JP, was appointed as an independent non-executive Director in August 2017.  Mdm. Shing was appointed as a Justice of Peace of the HKSAR in 2013 and awarded Bronze Bauhinia Star in 2017. Mdm. Shing is currently the chairman of Yinn Advisory Services Limited and an independent non-executive director of CSSC (Hong Kong) Shipping Company Limited (listed on the Stock Exchange, stock code: 3877), AEON Credit Service (Asia) Company Limited (listed on the Stock Exchange, stock code: 900) and an independent director of China Merchants Energy Shipping Company Limited (listed on Shanghai Stock Exchange, stock code: 601872). Mdm. Shing was a partner of Deloitte China for over 26 years until her retirement in May 2016. She is also a member of the 10th, 11th and 12th Jiangsu Provincial Committee of the CPPCC. Mdm. Shing is a founding member and past president of the Association of Women Accountants (Hong Kong) and the former chairman of Hong Kong Institute of Certified Public Accountants Taxation Committee. Her professional qualifications include fellow member of the Hong Kong Institute of Certified Public Accountants, Association of Chartered Certified Accountants and Institute of Chartered Secretaries and Administrators. Mdm. Shing’s current public appointments include treasurer of the Council of the Hong Kong Academy for Performing Arts, member of the Communications Authority, court member of the Hong Kong Polytechnic University, and advisor and member of the Finance Committee of Our Hong Kong Foundation. In 2006, Mdm. Shing received the National Hundred Outstanding Women Entrepreneurs Award in Great Hall of the People in Beijing. She also received the Outstanding Alumni Award of Hong Kong Polytechnic University in 2007. Mdm. Shing has been consecutively named from 2001 to 2015 in International Tax Review as one of the World’s Leading Tax Advisors in Hong Kong and Mainland. Mdm. Shing graduated from the Hong Kong Polytechnic (currently known as the Hong Kong Polytechnic University) and obtained a Higher Diploma in Accountancy and was awarded in 2016/2017 Honorary University Fellow of the Hong Kong Polytechnic University.

Kwok Kin Fun - Independent Non-executive Director


Mr. Kwok Kin Fun, BBS, JP, was appointed as an independent non-executive Director in June 2016. Mr. Kwok also serves as an Executive Committee member of Rehabilitation International and global Vice Chairman of Social Commission of Rehabilitation International, the chairman of Incheon Strategy Group Committee of Asia and Pacific Disability Forum, a vice chairman of The Hong Kong Joint Council for People with Disabilities, a vice chairman of The Hong Kong Society for Rehabilitation, the chairman of Fu Hong Society, a member of Ethics Research Committee of Hospital Authority Kowloon Central and Kowloon East Clusters, a member of Voting Members Committee of Riding For the Disabled Association, the chairman of Accessible IT Development Association Limited. Mr. Kwok has over 30 years of experience in disability research and medical research ethics. He successively served as a senior lecturer, a principal lecturer, a university senior lecturer and an associate professor of the City University of Hong Kong from 1985 to 2009, and after retirement served as full-time and part-time senior research fellow. Mr. Kwok was appointed as a Justice of the Peace by the government of Hong Kong in 1997 and received the Bronze Bauhinia Star awarded by the government of Hong Kong SAR in 2005, “Kazuo Itoga” Memorial Prize awarded by the government of Shiga Prefecture, Japan in 2006, and the Promoter title of “Asian and Pacific Decade of Persons with Disabilities, 2013–2022” awarded by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) in 2012. Mr. Kwok holds a bachelor’s degree in social science from the University of Hong Kong, a master’s degree in social science from the Chinese University of Hong Kong, and a Ph.D. degree from the University of Nottingham, the UK.

Fu Tingmei - Independent Non-executive Director


Mr. Fu Tingmei, was appointed as an independent non-executive Director in June 2016. Mr. Fu has over 20 years of experience in investment, finance, law and business management. Mr. Fu currently serves as an independent non-executive director of Guotai Junan International Holdings Limited, a company listed on the Stock Exchange (stock code: 1788), Postal Savings Bank of China Co., Ltd., a company listed on the Stock Exchange (stock code: 1658) and COFCO Joycome Foods Limited (formerly known as: COFCO Meat Holdings Limited), a company listed on the Stock Exchange (stock code: 1610). Mr. Fu was an independent non-executive director of Beijing Enterprises Holdings Limited, a company listed on the Stock Exchange (stock code: 0392) from July 2008 to June 2017 and an independent non-executive director of CPMC Holdings Limited, a company listed on the Stock Exchange (stock code: 0906) from June 2008 to July 2019. Mr. Fu holds a master’s degree in law and a Ph.D. degree in law from London University, the United Kingdom.

 

Zhang Kejian - Independent Non-executive Director


Mr. Zhang Kejian, was appointed as an independent non-executive Director in June 2016. Mr. Zhang also serves as an independent director of Zhejiang Hisoar Pharmaceutical Co. Ltd. (a company listed on Shenzhen Stock Exchange, stock code: 002099), and independent director of Guangzhou Boji Medical Biotechnological Co.,Ltd.a company listed on Shenzhen Stock Exchange GEM, stock code: 300404and the Chief Scientist of The South China Center for Innovative Pharmaceuticals. Mr. Zhang has over 20 years of experience in the pharmaceutical industry of PRC. He was an independent director of CR Double-Crane, a company listed on Shanghai Stock Exchange (stock code: 600062) from February 2016 to June 2018, an independent director of Yifan Pharmaceutical Co., Ltd. (a company listed on Shenzhen Stock Exchange, stock code: 002019) from October 2014 to November 2020 and an independent director of Hunan Fangsheng Pharmaceutical Co., Ltd (a company listed on Shanghai Stock Exchange, stock code: 603998) from October 2018 to January 2021. He was employed as a professor of School of Pharmaceutical Sciences of Sun Yat-sen University and the director (Pharmacy Administration) of The South China Center for Innovative Pharmaceuticals, a researcher at the Institute of Medicine, Chinese Academy of Medical Sciences(中国医学(xue)科学(xue)院药物研究所), and successively served as a deputy director of Pharmaceutical Evaluation Center(药品审评中心(xin))and a deputy director of Medical Device Evaluation Center(医疗器械技(ji)术审评中心)under the State Food and Drug Administration of the PRC(国家食(shi)品药品监(jian)督(du)管理局). Mr. Zhang received a master’s degree in pathophysiology from China Medical University in Shenyang, the PRC and a doctor’s degree in pharmacy from the School of Pharmaceutical Sciences of Chiba University in Chiba, Japan.

Back to Top
网狐棋牌服务端分析最近的麻将馆棋牌室